心臓弁の市場規模、シェア、成長分析：タイプ別、部位別、治療法別、エンドユーザー別、地域別 - 産業予測 2025～2032年

心臓弁の世界市場規模は2023年に86億米ドルと評価され、予測期間（2025-2032年）のCAGRは11.4%で、2024年の95億8,000万米ドルから2032年には227億2,000万米ドルに成長する見通しです。

2023年10月現在、技術の進歩は心不全と心血管疾患管理に革命をもたらし、革新的な治療ソリューションへの道を開いています。心疾患の有病率の上昇に伴い、臨床診療の再構築を約束する最先端製品の開発に注目が集まっています。業界大手各社は斬新な製品を投入し、市場成長を促進し、治療手法を強化しています。2023年から2030年にかけて大幅な拡大が見込まれる心臓弁市場は、主に心血管疾患に罹患する世界人口の急増に後押しされています。弁膜症や冠動脈疾患など、さまざまな心臓疾患の罹患率が増加していることが、心臓弁の交換需要に拍車をかけています。これらのインプラントは心機能を回復させ、患者の予後改善につながる重要な役割を担っています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次と一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• 規制情勢
• ケーススタディ
• 技術の進歩

心臓弁市場規模：タイプ別& CAGR（2025-2032）

• 市場概要
• 経カテーテル心臓弁
• 組織心臓弁
• 人工心臓弁
• その他

心臓弁市場規模：部位別& CAGR（2025-2032）

• 市場概要
• 僧帽弁
• 大動脈弁
• その他の部位

心臓弁市場規模：治療法別& CAGR（2025-2032）

• 市場概要
• 心臓弁の修復
• 心臓弁の置換

心臓弁市場規模：エンドユーザー別& CAGR（2025-2032）

• 市場概要
• 心臓調査
• 病院と診療所
• 専門センター
• その他

心臓弁市場規模：地域別& CAGR（2025-2032）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 最近の市場動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 企業の詳細
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比比較（2022-2024）

主要企業プロファイル

• Medtronic（Ireland）
• Edwards Lifesciences（United States）
• Boston Scientific（United States）
• Abbott Laboratories（United States）
• LivaNova（United Kingdom）
• CryoLife（United States）
• MicroPort Scientific（China）
• Braile Biomedica（Brazil）
• TTK Healthcare（India）
• Colibri Heart Valve（United States）
• Venus Medtech（China）
• Peijia Medical（China）
• Lepu Medical Technology（China）
• Meril Life Sciences（India）
• Biotronik（Germany）
• Neovasc（Canada）
• Cardiac Dimensions（United States）
• HighLife Medical（France）
• Mardil Medical（United States）

結論と提言

Global Cardiac Valve Market size was valued at USD 8.6 billion in 2023 and is poised to grow from USD 9.58 billion in 2024 to USD 22.72 billion by 2032, growing at a CAGR of 11.4% during the forecast period (2025-2032).

As of October 2023, technological advancements are revolutionizing heart failure and cardiovascular disease management, paving the way for innovative treatment solutions. With the rising prevalence of cardiac conditions, there's an intensified focus on developing cutting-edge products that promise to reshape clinical practices. Major industry players are introducing novel offerings, driving market growth and enhancing treatment methodologies. The cardiac valve market, expected to expand significantly between 2023 and 2030, is primarily propelled by the rapid increase in the global population suffering from cardiovascular diseases. The growing incidence of various heart ailments, including valvular disorders and coronary artery disease, has spurred demand for cardiac valve replacements. These implants play a crucial role in restoring cardiac function, leading to improved patient outcomes.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cardiac Valve market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cardiac Valve Market Segments Analysis

Global Cardiac Valve Market is segmented by Type, Position, Treatment, End User and region. Based on Type, the market is segmented into Trans-Catheter Heart Valve, Tissue Heart Valve, Mechanical Heart Valve and Others. Based on Position, the market is segmented into Mitral Valve, Aortic Valve and Other Position. Based on Treatment, the market is segmented into Cardiac Valve Repair and Cardiac Valve Replacement. Based on End User, the market is segmented into Cardiac Research Institute, Hospital and Clinics, Speciality centers and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Cardiac Valve Market

The growth of the Global Cardiac Valve market is primarily driven by an increasing elderly population and a trend toward more sedentary lifestyles. Furthermore, advancements in heart valve technology and a growing awareness of surgical options are contributing to this expansion, particularly as patients prefer minimally invasive procedures. According to the American College of Cardiology, around 5 million Americans are diagnosed with heart valve disease each year, highlighting the urgent need for effective treatments and interventions. This combination of demographic changes, technological innovations, and patient preferences underscores the significant potential for growth within the cardiac valve market.

Restraints in the Global Cardiac Valve Market

The Global Cardiac Valve market faces significant challenges primarily due to stringent government regulations overseeing the development, production, and application of medical devices, particularly cardiac valves. Adherence to these regulatory guidelines requires a complex and labor-intensive process, which involves extensive testing and comprehensive documentation to ensure the safety and efficacy of these devices. This meticulous compliance not only prolongs the time required for product development but also adds considerable costs, ultimately hindering market growth and innovation within the cardiac valve sector. As a result, navigating these regulatory hurdles can deter new entrants and limit advancements in this specialized market.

Market Trends of the Global Cardiac Valve Market

The global cardiac valve market is witnessing robust growth, primarily driven by the rising prevalence of heart valve diseases and the introduction of innovative and regulated cardiac valve solutions. The increasing incidence of conditions such as rheumatic heart disease, affecting approximately 39 million people worldwide according to the World Heart Federation's 2022 data, highlights a significant market need. Additionally, advancements in technology and materials in valve design are enhancing patient outcomes, thereby accelerating adoption rates. This trend reflects a broader healthcare focus on improving cardiovascular health, positioning cardiac valves as a critical area of investment and development within the medical device industry.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies
• Technological Advancement

Global Cardiac Valve Market Size by Type & CAGR (2025-2032)

• Market Overview
• Trans-Catheter Heart Valve
• Tissue Heart Valve
• Mechanical Heart Valve
• Others

Global Cardiac Valve Market Size by Position & CAGR (2025-2032)

• Market Overview
• Mitral Valve
• Aortic Valve
• Other Position

Global Cardiac Valve Market Size by Treatment & CAGR (2025-2032)

• Market Overview
• Cardiac Valve Repair
• Cardiac Valve Replacement

Global Cardiac Valve Market Size by End User & CAGR (2025-2032)

• Market Overview
• Cardiac Research Institute
• Hospital and Clinics
• Speciality centers
• Others

Global Cardiac Valve Market Size & CAGR (2025-2032)

• North America (Type, Position, Treatment, End User)
  • US
  • Canada
• Europe (Type, Position, Treatment, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Position, Treatment, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Position, Treatment, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Position, Treatment, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Medtronic (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Edwards Lifesciences (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LivaNova (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CryoLife (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MicroPort Scientific (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Braile Biomedica (Brazil)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• TTK Healthcare (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Colibri Heart Valve (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Venus Medtech (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Peijia Medical (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lepu Medical Technology (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Meril Life Sciences (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biotronik (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Neovasc (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardiac Dimensions (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HighLife Medical (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mardil Medical (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations